Prosecution Insights
Last updated: May 29, 2026

Examiner: SASAN, ARADHANA

Tech Center 1600 • Art Units: 1615 1654

This examiner grants 64% of resolved cases

Performance Statistics

64.4%
Allow Rate
+4.4% vs TC avg
1,169
Total Applications
+26.4%
Interview Lift
1150
Avg Prosecution Days
Based on 1108 resolved cases, 2023–2026

Rejection Statute Breakdown

0.5%
§101 Eligibility
2.4%
§102 Novelty
57.7%
§103 Obviousness
2.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18613904 COMPOSITIONS COMPRISING BIOACTIVE GLASS AND AMINO ACID Non-Final OA CORNING INCORPORATED
18432605 ANTIMICROBIAL BOTTLE WITH ANTIMICROBIAL SEAL Final Rejection Microban Products Company
18546602 AMORPHOUS FORM AND COMPOSITION CONTAINING SAID AMORPHOUS FORM Final Rejection OTSUKA PHARMACEUTICAL CO., LTD.
18011335 SAPONIN CONTAINING EXTRACTS PREPARED FROM HESPERALOE USEFUL IN THE TREATMENT OF NON-HUMAN ANIMALS Final Rejection KIMBERLY-CLARK WORLDWIDE, INC.
18690379 AQUEOUS COMPOSITION COMPRISING A FATTY DIALKYL ETHER, AN ANIONIC SURFACTANT WITH AT LEAST ONE CATIONIC COUNTERION AND A NONIONIC SURFACTANT Non-Final OA L'OREAL
18591930 COSMETIC COMPOSITION FOR ACNE CARE Final Rejection L'OREAL
18640463 METHOD OF PREPARING POUCH FILLING MATERIAL USING BINDER Non-Final OA KT&G Corporation
18093654 ORAL GEL COMPOSITIONS Non-Final OA Colgate-Palmolive Company
18291029 LIGHT-COLORED CATECHOL LIGNOSULFONATE SUNSCREEN MICROCAPSULE, AND PREPARATION THEREFOR AND USE THEREOF Non-Final OA South China University of Technology
18023119 COMPOSITION FOR AMELIORATING UNPLEASANT STATE CAUSED BY MENSTRUATION Non-Final OA ROHTO PHARMACEUTICAL CO., LTD.
18016189 COMPOSITIONS AND METHODS OF TREATING UPS-ASSOCIATED DISEASES Final Rejection Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
18700578 LOW BACK PAIN TREATMENT Non-Final OA Persica Pharmaceuticals Ltd.
18697581 A Nano Emulsified Phyto-Drug For Transdermal Treatment of Diabetes Non-Final OA University of South Africa
18585371 SUNSCREEN PREPARATION Non-Final OA BEIERSDORF AG
18568202 DISSOLUTION RESISTANT TISSUE ADHERENT DRESSING APPLICATION AND ITS DELIVERY Non-Final OA TRICOL BIOMEDICAL, INC.
18541626 COMPOSITION COMPRISING AT LEAST ONE NATURAL OR SYNTHETIC N-ALKYLAMIDE AS ACTIVE SUBSTANCE AND ITS MANUFACTURING PROCESS Non-Final OA TILMAN
18568415 PHARMACEUTICAL COMPOSITION, PREPARATION, AND PREPARATION METHOD THEREFOR AND USE THEREOF Non-Final OA WUHAN LL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD.
18567140 METHODS FOR THE PULSED DELIVERY OF BIOACTIVE AGENTS Final Rejection David Allen PULEO
18525295 COMPOSITIONS COMPRISING POROUS MICROPARTICLES AND METHODS OF USING THE SAME Non-Final OA WEST CHESTER UNIVERSITY
18564552 CO-AMORPHOUS FORMS FOR USE IN CANCER THERAPY Non-Final OA Zerion Pharma APS
18562212 ORODISPERSIBLE EFFERVESCENT TABLET COMPRISING BUDESONIDE FOR USE IN THE TREATMENT OF EOSINOPHILIC ESOPHAGITIS Non-Final OA Dr. Falk Pharma GmbH
18552711 ADHESIVE MICROCAPSULES FOR MECHANICALLY-RESPONSIVE THERAPEUTIC DELIVERY Non-Final OA THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARMENT OF VETERANS AFFAIRS
18283585 PHARMACEUTICAL COMPOSITION FOR IMPROVING CARDIAC FUNCTION Final Rejection CUORIPS INC.
18551592 SUPERABSORBENT HYDROGELS Final Rejection JUNION LABS PTE. LTD.
18467324 Compositions of Iboga Alkaloids and Methods of Treatment Non-Final OA Soneira Inc., P.B.C.
18451355 Food Contact Disinfecting/Sanitizing Formulation And Wipe Final Rejection ARXADA, LLC
18276396 INHALABLE IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF Non-Final OA Aerovate Therapeutics, Inc.
18272796 AMLODIPINE DRY SUSPENSION AND PREPARATION METHOD THEREFOR Non-Final OA APICHOPE BIO PHARMACEUTICAL CO., LTD.
18195713 BRAIN HEALTH SUPPLEMENTS Final Rejection Melaleuca, Inc.
18034878 COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING CORONAVIRUSES Non-Final OA NOVATEK THERAPEUTICS, LLC

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month